Nicotine in Parkinson's Disease - a Therapeutic Track Gone up in Smoke?

Pierre-François Charbonneau, Philippe Damier

Journal: NEJM evidence 2024;2(9):EVIDe2300167

PMID: 38320201

Abstract

In recent decades, numerous studies have found that smoking or the intake of any form of nicotine, such as smokeless tobacco, exposure to environmental tobacco smoke, or even dietary sources such as peppers, reduces the risk of developing Parkinson's disease. Such observations suggest a potential disease-modifying effect of nicotine in Parkinson's disease. Many experimental studies, some of them supported by grants from the tobacco industry, have lent support for such a hypothesis.

Address: Nantes University, Centre Hospitalier Universitaire Nantes, Institut National de la Santé et de la Recherche Médicale, centre d'investigation clinique 1413, neuroscience Parkinson/French Clinical Research Infrastructure Network, Nantes, France.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.